13G TROV 08.13.12

Company

Cardiff Oncology, Inc.

Filed

August 13, 2012

Accession Number

0001535610-12-000013

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →